Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma

BackgroundColon adenocarcinoma (COAD) can be divided into left-sided and right-sided COAD (LCCs and RCCs, respectively). They have unique characteristics in various biological aspects, particularly immune invasion and prognosis. The purpose of our study was to develop a prognostic risk scoring model...

Full description

Bibliographic Details
Main Authors: Jun-Nan Guo, Ming-Qi Li, Shen-Hui Deng, Chen Chen, Yin Ni, Bin-Bin Cui, Yan-Long Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.640196/full
_version_ 1818849694004019200
author Jun-Nan Guo
Ming-Qi Li
Shen-Hui Deng
Chen Chen
Yin Ni
Bin-Bin Cui
Yan-Long Liu
author_facet Jun-Nan Guo
Ming-Qi Li
Shen-Hui Deng
Chen Chen
Yin Ni
Bin-Bin Cui
Yan-Long Liu
author_sort Jun-Nan Guo
collection DOAJ
description BackgroundColon adenocarcinoma (COAD) can be divided into left-sided and right-sided COAD (LCCs and RCCs, respectively). They have unique characteristics in various biological aspects, particularly immune invasion and prognosis. The purpose of our study was to develop a prognostic risk scoring model (PRSM) based on differentially expressed immune-related genes (IRGs) between LCCs and RCCs, therefore the prognostic key IRGs could be identified.MethodsThe gene sets and clinical information of COAD patients were derived from TCGA and GEO databases. The comparison of differentially expressed genes (DEGs) of LCCs and RCCs were conducted with appliance of “Limma” analysis. The establishment about co-expression modules of DEGs related with immune score was conducted by weighted gene co-expression network analysis (WGCNA). Furthermore, we screened the module genes and completed construction of gene pairs. The analysis of the prognosis and the establishment of PRSM were performed with univariate- and lasso-Cox regression. We employed the PRSM in the model group and verification group for the purpose of risk group assignment and PRSM accuracy verification. Finally, the identification of the prognostic key IRGs was guaranteed by the adoption of functional enrichment, “DisNor” and protein-protein interaction (PPI).ResultsA total of 215 genes were screened out by differential expression analysis and WGCNA. A PRSM with 16 immune-related gene pairs (IRGPs) was established upon the genes pairing. Furthermore, we confirmed that the risk score was an independent factor for survival by univariate- and multivariate-Cox regression. The prognosis of high-risk group in model group (P < 0.001) and validation group (P = 0.014) was significantly worse than that in low-risk group. Treg cells (P < 0.001) and macrophage M0 (P = 0.015) were highly expressed in the high-risk group. The functional analysis indicated that there was significant up-regulation with regard of lymphocyte and cytokine related terms in low-risk group. Finally, we identified five prognostic key IRGs associated with better prognosis through PPI and prognostic analysis, including IL2RB, TRIM22, CIITA, CXCL13, and CXCR6.ConclusionThrough the analysis and screening of the DEGs between LCCs and RCCs, we constructed a PRSM which could predicate prognosis of LCCs and RCCs, and five prognostic key IRGs were identified as well. Therefore, the basis for identifying the benefits of immunotherapy and immunomodulatory was built.
first_indexed 2024-12-19T06:37:18Z
format Article
id doaj.art-84fa4d450e194174b6e87fc6d9572b28
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-19T06:37:18Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-84fa4d450e194174b6e87fc6d9572b282022-12-21T20:32:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.640196640196Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon AdenocarcinomaJun-Nan Guo0Ming-Qi Li1Shen-Hui Deng2Chen Chen3Yin Ni4Bin-Bin Cui5Yan-Long Liu6Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Anesthesiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin, ChinaBackgroundColon adenocarcinoma (COAD) can be divided into left-sided and right-sided COAD (LCCs and RCCs, respectively). They have unique characteristics in various biological aspects, particularly immune invasion and prognosis. The purpose of our study was to develop a prognostic risk scoring model (PRSM) based on differentially expressed immune-related genes (IRGs) between LCCs and RCCs, therefore the prognostic key IRGs could be identified.MethodsThe gene sets and clinical information of COAD patients were derived from TCGA and GEO databases. The comparison of differentially expressed genes (DEGs) of LCCs and RCCs were conducted with appliance of “Limma” analysis. The establishment about co-expression modules of DEGs related with immune score was conducted by weighted gene co-expression network analysis (WGCNA). Furthermore, we screened the module genes and completed construction of gene pairs. The analysis of the prognosis and the establishment of PRSM were performed with univariate- and lasso-Cox regression. We employed the PRSM in the model group and verification group for the purpose of risk group assignment and PRSM accuracy verification. Finally, the identification of the prognostic key IRGs was guaranteed by the adoption of functional enrichment, “DisNor” and protein-protein interaction (PPI).ResultsA total of 215 genes were screened out by differential expression analysis and WGCNA. A PRSM with 16 immune-related gene pairs (IRGPs) was established upon the genes pairing. Furthermore, we confirmed that the risk score was an independent factor for survival by univariate- and multivariate-Cox regression. The prognosis of high-risk group in model group (P < 0.001) and validation group (P = 0.014) was significantly worse than that in low-risk group. Treg cells (P < 0.001) and macrophage M0 (P = 0.015) were highly expressed in the high-risk group. The functional analysis indicated that there was significant up-regulation with regard of lymphocyte and cytokine related terms in low-risk group. Finally, we identified five prognostic key IRGs associated with better prognosis through PPI and prognostic analysis, including IL2RB, TRIM22, CIITA, CXCL13, and CXCR6.ConclusionThrough the analysis and screening of the DEGs between LCCs and RCCs, we constructed a PRSM which could predicate prognosis of LCCs and RCCs, and five prognostic key IRGs were identified as well. Therefore, the basis for identifying the benefits of immunotherapy and immunomodulatory was built.https://www.frontiersin.org/articles/10.3389/fonc.2021.640196/fullcolon adenocarcinoma (COAD)left-sidedright-sidedimmune-related genes (IRGs)prognosis
spellingShingle Jun-Nan Guo
Ming-Qi Li
Shen-Hui Deng
Chen Chen
Yin Ni
Bin-Bin Cui
Yan-Long Liu
Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
Frontiers in Oncology
colon adenocarcinoma (COAD)
left-sided
right-sided
immune-related genes (IRGs)
prognosis
title Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
title_full Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
title_fullStr Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
title_full_unstemmed Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
title_short Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma
title_sort prognostic immune related analysis based on differentially expressed genes in left and right sided colon adenocarcinoma
topic colon adenocarcinoma (COAD)
left-sided
right-sided
immune-related genes (IRGs)
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2021.640196/full
work_keys_str_mv AT junnanguo prognosticimmunerelatedanalysisbasedondifferentiallyexpressedgenesinleftandrightsidedcolonadenocarcinoma
AT mingqili prognosticimmunerelatedanalysisbasedondifferentiallyexpressedgenesinleftandrightsidedcolonadenocarcinoma
AT shenhuideng prognosticimmunerelatedanalysisbasedondifferentiallyexpressedgenesinleftandrightsidedcolonadenocarcinoma
AT chenchen prognosticimmunerelatedanalysisbasedondifferentiallyexpressedgenesinleftandrightsidedcolonadenocarcinoma
AT yinni prognosticimmunerelatedanalysisbasedondifferentiallyexpressedgenesinleftandrightsidedcolonadenocarcinoma
AT binbincui prognosticimmunerelatedanalysisbasedondifferentiallyexpressedgenesinleftandrightsidedcolonadenocarcinoma
AT yanlongliu prognosticimmunerelatedanalysisbasedondifferentiallyexpressedgenesinleftandrightsidedcolonadenocarcinoma